Show simple item record

dc.contributor.authorNyasani, DK
dc.contributor.authorMutua, GN
dc.contributor.authorSajabi, RM
dc.contributor.authorNg'ang'a, JW
dc.contributor.authorGachie, JN
dc.contributor.authorMaina, AM
dc.contributor.authorLusike, LL
dc.contributor.authorAnzala, AO
dc.contributor.authorPrice, MA
dc.contributor.authorManyonyi, GO
dc.date.accessioned2019-07-04T12:05:41Z
dc.date.available2019-07-04T12:05:41Z
dc.date.issued2018-11-02
dc.identifier.citationPLoS One. 2018 Nov 2;13(11en_US
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pubmed/30388145
dc.identifier.urihttp://erepository.uonbi.ac.ke/handle/11295/106534
dc.description.abstractOBJECTIVE: To evaluate initial reported willingness to participate in a hypothetical HIV vaccine clinical trial and actual participation of volunteers in a longitudinal observational study. METHODS: We recruited HIV negative male and female volunteers aged 18-45 years into a longitudinal observational study at KAVI-ICR Kangemi in Kenya, to serve as a pool from which to draw participants into a phase I HIV vaccine clinical trial. A structured questionnaire was used to collect information regarding willingness to join a HIV vaccine clinical trial in the future. Study follow-up visits were every 6 months. RESULTS: A total of 105 participants were screened and 100 (M46:F54) were enrolled into the observational study. Ninety- four per cent of those enrolled expressed willingness to participate in a future HIV vaccine trial. Altruism and desire to learn the body's response to the vaccine were the most motivating factors at 40% and 25% respectively. At the onset of a 40-person phase I HIV vaccine trial, 86 observational study participants who had previously expressed willingness to participate were contacted but only 26 (30%) came for information. All 26 consented to participate and after screening for eligibility, 24 were eligible. Of the 24, 15 were enrolled. These numbers were not adequate; hence the vaccine trial employed other recruitment methods to meet the deficit. CONCLUSION: Observational "pools" of cohorts may not provide adequate number of participants into vaccine clinical trials even if they report willingness; therefore supplementary recruitment methods such as direct community recruitment, passive approach, and snowballing need to be in place.en_US
dc.language.isoenen_US
dc.publisherPLoSen_US
dc.titleReported willingness to participate in a hypothetical HIV vaccine trial and its translation to actual participation among healthy adults-Experience from Kenya.en_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record